Avenda spotlights AI prostate cancer study

2019 05 03 20 23 2154 Prostate 3 D 400

AI software developer Avenda Health is highlighting clinical results that suggest its Unfold AI imaging software is effective in prostate cancer patients.

Unfold AI uses deep-learning algorithms to combine patient-specific data from prostate imaging, biopsies, and pathology to create a 3D cancer estimation map. This map can help physicians visualize the extent of a patient's prostate cancer and provide more personalized treatments, according to the vendor.

In the study, Unfold AI produced a cancer estimation map for 50 patients showing voxel-level predictions of clinically significant prostate cancer, with a mean area under the curve of 0.911, according to the findings.

The study was published online June 13 in European Urology Open Science.

Page 1 of 109
Next Page